Abstract
The present study investigated the fate of macrophages in peripheral nerves undergoing Wallerian degeneration, especially their disappearance from the injured nerves after phagocytosis of axonal and myelin debris. Wallerian degeneration was induced in adult male C57Bl/6 mice by transecting the right sciatic nerve. Five days after transection, the male sciatic nerves were transplanted into female recipient mice by placing them exactly parallel to the host sciatic nerves. Nerves of the female recipient mice were also transected to induce breakdown of the blood–nerve barrier in the host animal. Apoptosis was assessed by morphological, immunohistochemical (activated caspase-3), and molecular (DNA fragmentation) methods in transplanted, recipient, and in control nerves. A subpopulation of macrophages within the degenerating nerves died locally by apoptosis in each experiment. The fate of the male macrophages within the transplanted nerves and the host organism was investigated by in situ hybridization with a Y-chromosome-specific DNA probe (145SC5). In situhybridization specifically stained cells within the transplanted male nerve. Y-chromosome-positive cells were detected not only inside the transplanted nerve, but also inside the female host nerve, the perineurial tissue, the local perineurial blood vessels, draining lymph nodes and the spleen of the female host, suggesting hematogenous as well as lymphatic elimination of macrophages from the injured nerve. These data indicate that local apoptosis and systemic elimination via circulation to the local lymph nodes and the spleen are involved in the disappearance of macrophages from the injured peripheral nervous system.
The mechanisms that affect and regulate macrophage infiltration of peripheral nerves during Wallerian degeneration have extensively been investigated in recent years (Stoll and Hartung, 1992; Griffin and Hoffman, 1993; Brück, 1997). Disconnection of the axon through traumatic, toxic, degenerative, ischemic, or metabolic damage leads to calcium-dependent axonal degeneration, retraction of Schwann cell cytoplasm from myelin sheaths, and formation of myelin ovoids within the first 24 hr (Beuche and Friede, 1984; Griffin and Hoffman, 1993; George et al., 1995). These events are followed by intense Schwann cell proliferation and recruitment of hematogenous and resident macrophages, which remove the degenerated myelin (Stoll et al., 1989; Fernandez-Valle et al., 1995;Brück et al., 1996a; Brück, 1997). Factors of axonal origin, complement components, adhesion molecules, and degenerating myelin itself attract macrophages to migrate into transected nerves (Brück and Friede, 1990, 1991; Griffin et al., 1992; Brück et al., 1995; Brown et al., 1997; Vougioukas et al., 1998).
So far, no studies have been published that investigate the mechanisms or pathways leading to the disappearance of macrophages from the damaged peripheral nerves. From other experimental models of tissue injury such as experimental autoimmune encephalomyelitis (EAE) or myocardial infarction it is known that local apoptosis is involved in the elimination of infiltrating inflammatory cells (Nguyen et al., 1994, 1997; Smith et al., 1996; Takemura et al., 1998). Immunologically, the elimination of macrophages has been described as macrophage disappearance reaction; it is observed during delayed type hypersensitivity reactions and can be inhibited or induced by various stimuli (Barth et al., 1995).
The purpose of the present study was to clarify the mechanisms by which macrophages are eliminated from the injured peripheral nerve tissue. The following two hypotheses were tested: (1) macrophages are eliminated by local apoptosis or (2) macrophages migrate to local lymph nodes and the spleen. For these experiments, transected male sciatic nerves undergoing Wallerian degeneration were transplanted into female mice. The transplanted nerves were massively laden with macrophages and placed side-by-side to the host sciatic nerve, which was also transected. Apoptotic cells within the degenerating nerves were identified by morphologic criteria, DNA fragmentation (Brück et al., 1996b), and the antibody CM-1, which recognizes the large subunit of caspase-3 generated after activation (Srinivasan et al., 1998;Stadelmann et al., 1999). Activation of caspase-3 takes place in the effector phase of the apoptotic process, and its detection therefore represents a reliable tool for the identification of apoptotic cells. Transplanted macrophages were followed by in situhybridization with a Y-chromosome-specific probe (Singh et al., 1987;Grounds et al., 1991).
MATERIALS AND METHODS
Animal surgery and transplantation. All animal surgery was done in accordance with the German guidelines for animal experiments and was officially approved by the county government of Braunschweig (Germany). Wallerian degeneration was induced in 15 adult male and two female C57Bl/6 mice by transecting the right sciatic nerve under deep anesthesia with Ketanest (50 mg/ml; Parke-Davis, Courbevoie, France; 0.6 mg/10 gm body weight) and Rompun (2%; Bayer; 23.5 μl/10 gm body weight). The animals were decapitated under deep anesthesia 5 d after nerve transection. A uniform 5-mm-long piece of the degenerated sciatic nerve was immediately explanted and transplanted into 15 female or two male C57Bl/6 mice, respectively. The transplanted nerves were placed side-by-side to the host sciatic nerve, which was also transected to induce breakdown of the blood–nerve barrier. The transection sites of both the transplanted and the recipient nerve were aligned and fixed by a muscle suture. On days after transplantation (DPT) 2, 5, 10, 20, and 40, corresponding to days 7, 10, 15, etc. after transection, the mice were perfused under deep anesthesia through the left cardiac ventricle with PBS followed by 4% paraformaldehyde. Each experimental group consisted of three animals. Degenerating host and donor sciatic nerves, the contralateral nontransected host sciatic nerve, regional and para-aortal lymph nodes, as well as the spleen were removed from each animal, post-fixed in 4% paraformaldehyde, and embedded in paraffin wax. Additionally, three control animals were used in which transected sciatic nerves were allowed to degenerate for 6 d in situ in the absence of any transplantation procedure to control for effects of nerve transplantation on cell invasion or macrophage apoptosis. The 5-μm-thick sections of all tissues were stained with hematoxylin–eosin (H&E).
Immunohistochemistry. Immunohistochemistry was performed by using an avidin–biotin complex (ABC) technique on serial sections from the transected donor and host nerves. After deparaffinization, intrinsic peroxidase activity was blocked by incubation with 5% H2O2 in PBS for 20 min. Nonspecific antibody binding was inhibited with 10% fetal calf serum (FCS) in PBS for 25 min. The sections were stained with monoclonal antibodies against the macrophage antigens F4/80 (160 kDa glycoprotein; Serotec, Oxford, UK) and Mac-3 (PharMingen, San Diego, CA) at a dilution of 1:50 and 1:200, respectively. For further immunocytochemical staining we used polyclonal antisera or monoclonal antibodies directed against T cells (CD3; Serotec; dilution 1:400), the S-100 antigen (Dako, Glostrup, Denmark; dilution 1: 50) and activated caspase-3 (CM-1; kindly provided by T. L. Deckwerth and A. Srinivasan, Idun Pharmaceuticals, La Jolla, CA; dilution 1:5000). The CM-1 antibody is specific for the large subunit of caspase-3 and thus for the activated enzyme (Srinivasan et al., 1998). The slides were incubated overnight at 4°C. Microwave pretreatment (five times for 3 min at 800 W) was applied for the CD3, Mac-3, and CM-1 antibodies. Secondary antibodies were biotinylated anti-rat or anti-rabbit Ig (Dako) applied at a dilution of 1:200 for 60 min followed by incubation with the ABC complex (Vector Laboratories, Burlingame, CA) for 1 hr using diaminobenzidine (DAB) as chromogen. The primary antibody was omitted in control sections.
For double immunohistochemistry immunofluorescence procedures were used. The binding of the primary antibodies (CM-1, Mac-3) was visualized using Oregon green (Mobitec)- or Cy3 (Jackson ImmunoResearch, West Grove, PA)-coupled secondary reagents. The slides were examined on a Zeiss confocal laser-scanning microscope (LSM 510).
Semithin sections. Two C57Bl/6 mice were decapitated under deep anesthesia 10 d after transection of the right sciatic nerve. The distal nerve stumps were removed and immediately fixed in 2.5% glutaraldehyde and post-fixed in 1% osmium tetroxide. Specimens were dehydrated in graded concentrations of alcohol, passed through propylene oxide, and embedded in Araldite. Semithin sections (1 μm) were stained with Richardson's staining solution (1% Azur II, 2% Methyleneblue, 1% Borax).
In situ tailing. The in situ tailing technique (IST) was performed as described in detail elsewhere (Gold et al., 1993). Sections were deparaffinized and then incubated for 1 hr at 37°C in a reaction mix containing 10 μl of 5× tailing buffer, 2 μl of cobalt chloride, 1 μl of digoxigenin labeling mixture (nucleotides), and 6 U of terminal transferase. Distilled water was added to give a total volume of 50 μl. Sections were washed in TBS, followed by incubation with alkaline phosphatase-labeled anti-digoxigenin antibody (diluted 1:250 in distilled water containing 10% FCS) for 1 hr at room temperature. The color reaction was developed with nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolylphosphate (BCIP). All reagents, enzymes, and antibodies were purchased from Boehringer Mannheim (Mannheim, Germany). IST-positive macrophages were detected by double immunohistochemistry with the antibody F4/80 as described above.
Probe synthesis and in situ hybridization. A DNA probe specific for the mouse Y-chromosome was generated by PCR. A 722 bp fragment of the mouse Y-chromosome was amplified from a plasmid containing a 1.5 kb sequence of the 145SC5 mouse Y-chromosome (a generous gift of L. Singh) (Singh et al., 1994). The PCR reaction mixture consisted of 40 ng of DNA, 5 μl of 10× buffer, 1.5 mm MgCl, 5 μl of PCR DIG Probe Synthesis Mix (2 mm dATP, dCTP, dGTP, 1.3 mmdTTP, and 0.7 mm DIG-11-dUTP), 2.5 μl of each primer (10 pmol/μl) (forward primer: 5′-GTG TCT GGT GTA AAC GGG CA; reverse primer: 5′-ACT TTT TGG ATC CAT CAT CTC T) and 2.5 U of polymerase mixture (Expand High Fidelity PCR System) in a total volume of 50 μl. All reagents were purchased from Boehringer Mannheim. The PCR profile consisted of 35 cycles of denaturation at 94°C for 1 min, annealing at 55°C for 30 sec and an extension at 72°C for 1 min. An initial denaturation step for 5 min and a prolonged extension step at 72°C for 10 min after the last cycle completed the PCR program. The amplification product was transferred to a 1% agarose gel. After electrophoresis the specific band was cut and purified by the Qiagen (Hilden, Germany) Extraction kit according to the manufacturer's protocol.
Nonradioactive in situ hybridization was performed as described earlier (Breitschopf et al., 1992). Slides were dewaxed in xylene and rehydrated. Proteinase K digestion (50 μg/ml) was performed at 37°C for 20 min. Sections were dehydrated in graded alcohol and chloroform. The hybridization mix was denatured in boiling water for 10 min and consisted of 5× SSC, 5% dextran sulfate, 0.01% salmon sperm DNA, 0.02% SDS, and the probe at a concentration of 0.2%. The slides with the hybridization mix were denatured for 5 min at 95°C. Hybridization was performed at 42°C for 12–16 hr. Sections were washed in 1× and 2× SSC at 37°C for 30 min each. Nonspecific antibody binding was prevented by incubation in Boehringer's blocking reagent with 10% FCS for 15 min. An anti-digoxigenin antibody conjugated to alkaline phosphatase (Boehringer Mannheim) was used at a dilution of 1:250 for 2–3 hr. The reaction product was visualized with NBT–BCIP. The signal was developed between 4 and 8 hr. As positive and negative controls, male and female mouse brain tissue was included in each in situhybridization.
Southern blot. A Southern blot was performed to control the specificity of the probe, in addition to the positive and negative controls for in situ hybridization. It is known that Y-chromosome probes may also recognize female DNA sequences (Shinohara et al., 1995) or may be strain-specific (Grounds et al., 1991). Genomic DNA was extracted from male and female mouse tails by using the Qiagen DNA Extraction kit according to the manufacturer's protocol. Five micrograms of DNA were digested with EcoRI and electrophoresed in a 1% agarose gel. DNA fragments were transferred to a positively charged nylon membrane (Sambrook et al., 1989). The filter was prehybridized with a mixture consisting of 50% formamide, 0.1%N-laurylsarcosine, 0.02% SDS, and 2% Boehringer blocking reagent for 2–3 hr at 42°C. The prehybridization mixture was discarded and replaced by a hybridization solution containing the same components as the prehybridization mixture, including the DIG-labeled probe. The incubation was continued for 16 hr. The filter was washed twice in 2× SSC and 0.1% SDS for 5 min at room temperature as well as twice in 0.5× SSC and 0.1% SDS for 15 min at 68°C. To prevent nonspecific antibody binding, the filter was incubated in Boehringer blocking reagent for 60 min. The filter was incubated with an anti-digoxigenin antibody conjugated to alkaline phosphatase (Boehringer Mannheim) at a dilution of 1:5000 for 30 min. The filter was washed twice in 0.1 m maleic acid, 0.1m NaCl, and 0.3% Tween 20. The signal was visualized with NBT–BCIP. A strong signal of 1.5 kb in the male (but not in the female) mouse DNA demonstrated the specificity of the probe used (Fig. 1). Hybridization with a probe for prion protein gene (2.2 kb) served as control for equal DNA content of the samples.
Morphometry and statistics. The numbers of Mac-3- or F4/80-positive macrophages were counted per square millimeter of degenerating nerve tissue in the transplanted and recipient nerves as well as in the transected nerves of the control animals. A standardized microscopic field of 10,000 μm2 was defined by an ocular morphometric grid at a final magnification of 1000×. Values represent numbers of stained cells per square millimeter (mean ± SD) per entire cross-section area of the nerves. The same procedure was used to determine the numbers of cells with apoptotic morphology stained in H&E sections, Mac-3-positive apoptotic cells, IST-positive cells, and CM-1-positive cells. The number of Y-chromosome-positive cells was determined semiquantitatively in the transplanted and recipient nerves, the perineurial tissue, the regional and para-aortal lymph nodes, as well as the spleen according to the following scheme: −, no positive cells; +, 1–4 positive cells; ++, 5–10 positive cells; +++, >10 positive cells. The Mann–WhitneyU test and the ANOVA test were used for statistical analysis. A p value < 0.05 was considered significant.
RESULTS
Morphology of the transected transplant and recipient nerves
Wallerian degeneration induces recruitment of monocytes from the circulation into the damaged nerves. Earlier experiments showed that this invasion takes place within the first 2–4 d after nerve transection (Brück, 1997). Accordingly at all times, the transplanted and the transected recipient, as well as the control nerves, were infiltrated by numerous macrophages. The phagocytes were found inside the endoneurial space as well as in the perineurium. This is shown for the transplanted nerves in Figure2, a and b, at DPT 5 and 20. Highest numbers of endoneurial macrophages in the transplanted nerves were observed on DPT 10, corresponding to day 15 after nerve transection. This increase in macrophage numbers was statistically significant (p < 0.05) when compared with the total number of endoneurial macrophages on DPT 2 and 5. The number of macrophages in the transplanted nerves then decreased significantly at DPT 20 (p < 0.05) and did not change until DPT 40 (Fig. 3a). A similar time course of endoneurial macrophage infiltration was observed within the recipient nerves, although at a slightly lower level (Fig. 3b). The number of endoneurial macrophages counted on days after transection 5–40 was significantly higher than those at day after transection 2 (p < 0.0005). Transected control nerves, which degenerated in the absence of any transplantation procedure, also revealed similar macrophage numbers (Fig. 3a,b). Within the perineurium of the nerves, slightly higher macrophage numbers were observed with a similar distribution in the different experimental groups (data not shown). Additionally, the perineurial inflammatory infiltrate of all transected nerves consisted of CD3-positive T-cells and some granulocytes. At the end of the observation periods, transplanted and recipient nerves were still aligned in most of the animals. However, nerve degradation especially in the transplanted nerve, was more advanced and did not allow exact measurement of nerve length at that time. This might be attributable to the lack of a continuous epineurial and perineurial nerve sheath that was still present in the distal degenerating nerve stump of the transected recipient nerves. However, this did not significantly affect cell invasion and macrophage apoptosis, as shown above and below.
Detection of apoptotic cells within the transected nerves
Morphological criteria
Endoneurial as well as perineurial cells with morphological criteria of apoptosis (nuclear and cytoplasmic condensation, margination of chromatin, formation of apoptotic bodies) were observed in the H&E stains (Fig. 2c), both in the transplanted and recipient nerves as well as in control nerves. Apoptotic endoneurial macrophages were seen at all time points after transplantation. By using the macrophage marker Mac-3, a maximum of 41 ± 35 endoneurial macrophages/mm2 revealed morphological signs of apoptosis on DPT 10 (corresponding to day 15 after transection) in the transplanted nerves, representing 4.5% of the entire endoneurial macrophage population (Fig. 3c). This increase of the number of apoptotic macrophages at DPT 10 was statistically significant (p < 0.05) when compared with the relative number of apoptotic macrophages at DPT 2 and 5 and DPT 20. In the recipient nerves, the highest numbers of apoptotic macrophages were observed on day 10 after transection (Fig.3d). Apoptosis of macrophages was also regularly observed in control nerves degenerating for 6 d. Thus, the presence of apoptotic macrophages seems to be a common phenomenon in nerves undergoing Wallerian degeneration and was not significantly affected by the transplantation procedure or the deprivation of the transplanted nerve from its distal ensheathed part. No major differences were seen in the number of apoptotic macrophages between the endoneurial and perineurial space (data not shown).
In additional experiments, control nerves were allowed to degeneratein situ for 10 d. In semithin sections of these nerves, numerous macrophages were seen. Axons and myelin sheaths degenerated, and the infiltrating macrophages extensively ingested the myelin fragments. Some of these macrophages contained a condensed and fragmented nucleus, changes typical for apoptosis (Fig. 2e). Additionally, a few macrophages were observed containing apoptotic bodies in their cytoplasms, which possibly represents phagocytosis of apoptotic cells by macrophages.
Detection of DNA fragmentation
Numerous cells with signs of DNA fragmentation were identified by the IST technique. IST-positive cells were observed in the endoneurium of transplanted as well as recipient nerves at all time points investigated (Fig. 2f). Cells with DNA fragmentation were also detected within the control nerves. Double staining of IST and the macrophage-specific antigen F4/80 revealed a subpopulation of macrophages that were IST-positive (Fig. 2g). Similar numbers of IST-positive macrophages were seen in recipient and control nerves (data not shown).
CM-1 antibody staining
In our study, CM-1-positive cells were observed in the endoneurium in all transplanted nerves and in recipient nerves from day 10 after transection on. Few CM-1-negative cells with morphological signs of apoptosis were observed (Fig. 2h). The highest numbers of CM-1-positive cells in transplanted nerves were found on DPT 10 and in recipient nerves at day 10 after transection, thus corresponding to the numbers of apoptotic macrophages detected by morphological criteria as described above. The numbers of CM-1-positive cells were slightly lower than the number of cells identified morphologically or by DNA fragmentation. Double immunofluorescence staining clearly identified CM-1-positive macrophages (Fig. 4).
Detection of 145SC5-positive cells by in situ hybridization
In situ hybridization with the Y chromosome-specific 145SC5 probe revealed a strong signal within the transplanted male nerves (Fig.5a,b), proving these cells to originate from the male donor animals. Numerous 145SC5-positive cells were seen at all time points after transplantation in the endoneurial and perineurial tissue of the transplanted nerve in all animals studied (Fig. 5c,d, Table 1). There were also Y chromosome-positive cells present in the female host nerve in 3 of 14 animals (Fig. 5e), indicating migration of these cells from the transplanted to the host nerve. The majority of the animals (13 of 14) revealed 145SC5-positive cells in the perivascular spaces (Fig. 5f) and sometimes also in regional lymph nodes (3 of 14 animals). Occasionally, Y chromosome-positive cells were seen closely attached to endothelial cells at the luminal surface of perineurial blood vessels (Fig. 5f), possibly indicating that these cells are in the process of crossing the endothelial cell layer. The presence of intraluminal cells is technically impossible to prove after perfusion of the animals. We also studied the presence of 145SC5-expressing cells in para-aortal lymph nodes. In all mice, positive cells were observed in the lymph nodes (Fig. 5g) but not in the perivascular spaces of the aorta or its branches. The highest numbers of positive cells were observed on DPT 20. In 10 of 15 animals, positive cells were also detected within the red and white pulp as well as in the marginal zone of the spleen (Fig. 5h, Table 1).
To confirm the bidirectional migration of host and donor cells, we transplanted two female sciatic nerve fragments into two male mice. Also in the female nerve segments some 145SC5-positive cells were detected (data not shown), indicating that host cells invaded the transplanted donor nerve.
DISCUSSION
Traumatic injury of peripheral nerves results in characteristic changes designated as Wallerian degeneration. The phenomenon of Wallerian degeneration includes myelin and axon degeneration as well as the influx of macrophages from the circulation, which remove the degenerating nerve structures. Macrophages also seem to be engaged in the initiation of regeneration by producing growth factors (Perry et al., 1987). The fate of the macrophages within the degenerating nerve is still unknown. Taking into account knowledge from other models of tissue injury, it seems possible that these cells die locally within the nerves or that alternatively they reach the systemic circulation and are eliminated in the lymph nodes or the spleen. The present series of experiments provides evidence for both local apoptosis of macrophages within the injured nerves as well as migration of these cells to local lymph nodes and spleen.
Our study unequivocally identified local apoptosis within the degenerating nerves as one mechanism by which macrophages are eliminated from the injured peripheral nervous system. Apoptosis of macrophages was confirmed with similar results in three independent tissue samples, namely within degenerating control nerves as well as within the graft and recipient nerves of the transplantation experiments. Therefore, it seems unlikely that local macrophage apoptosis in transplanted nerves is induced by the transplantation procedure itself or by the disconnection of the transplanted nerve from its distal part. The apoptotic nature of cell death was confirmed in the present study not only by morphological criteria, but also by detection of DNA fragmentation and activated caspase-3. In concert, these three different methods represent reliable tools to demonstrate apoptosis. Alternatively, fluorescence-activated cell sorting (FACS) analysis of dissociated cells from the degenerating nerves and double staining with Mac-3 and propidium iodide could also identify apoptotic macrophages in the nerves. However, we did not consider this method to be valuable for our experiments because the typical morphology would be lost, and the sensitivity of the detection of DNA fragmentation and activated caspase-3 would be compromised using the FACS method.
Apoptosis is an active process characterized by nuclear and cytoplasmic condensation and disintegration of the cell into membrane-bound fragments, so called apoptotic bodies (Lo et al., 1995). Additionally, activated caspase-3 is considered to be a central apoptotic effector enzyme in many experimental paradigms, located beyond the point of no return in the cell death program. Cells with prominent activation of caspase-3 are prone to die (Srinivasan et al., 1998; Thornberry and Lazebnik, 1998). Initiation of the caspase cascade finally leads to the cleavage of proteins critical for cell survival and to the activation of endonucleases resulting in DNA fragmentation (Thornberry and Lazebnik, 1998). In transected nerves, we detected higher numbers of cells with signs of DNA fragmentation than clearly apoptotic cells. This may be attributable to the fact that DNA fragmentation can be also found in necrotic cells (Grasl-Kraupp et al., 1995). Techniques that detect DNA strand breaks can therefore not be considered specific for apoptotic cell death, and this may explain our findings.
The low numbers of apoptotic macrophages in transected peripheral nerves are in accordance with results obtained in experimental autoimmune encephalomyelitis (EAE), in which also only few apoptotic macrophages were detected (Nguyen et al., 1994, 1997; Smith et al., 1996; White et al., 1998). The ineffective elimination of macrophages from the nervous system may finally lead to the known long-term accumulation of macrophages in the perivascular spaces after CNS injury (Kösel et al., 1997; Nguyen et al., 1997). The reasons for the relatively low rate of macrophage apoptosis as well as the exact mechanisms that regulate this process are still unclear. A very simple explanation might be the fact that the morphologically visible stages of apoptosis require only ∼4 hr for completion, and therefore only few apoptotic cells are observed at a single time point (Bursch et al., 1990; Grasl-Kraupp et al., 1995). It is known, however, that macrophages are relatively resistant to apoptosis compared with monocytes. A possible explanation is the upregulation of Flip (FLICE inhibitory protein), which blocks the FAS-mediated apoptotic pathway (Perlman et al., 1999). It was also shown that activation of monocytes results in an increased resistance to apoptosis associated with a downregulation of caspase-8 and an increased expression of the Bfl-gene, an antiapoptotic member of the bcl-2 family (Perera and Waldmann, 1998). In addition to Fas/FasL, an induction of apoptosis through TRAIL- and TWEAK-mediated pathways has been described (Kaplan et al., 2000). In vitro experiments have demonstrated that the apoptotic cell death of macrophages is regulated by activation of caspases 3 and 8 (Fahy et al., 1999). In our experiments, the number of cells positive for CM-1, an antibody against activated caspase-3, was generally lower compared with the number of cells with morphological characteristics of apoptosis. In fact, some apoptotic but CM-1-negative cells were seen, indicating that CM-1 does not detect all stages of programmed cell death, as described earlier (Stadelmann et al., 1999) or that some cells may less likely undergo a caspase-independent apoptotic pathway (Susin et al., 1999).
Our data suggest that the systemic elimination of macrophages via lymph nodes and spleen is involved in macrophage disappearance from the injured peripheral nerve. We demonstrate that macrophages from the transplanted nerve also invaded the recipient nerve and vice versa. A Y-chromosome-specific DNA probe was used to follow transplanted cells on their way through the host organism. This tool has been shown to be a reliable marker for transplanted cell populations in different experimental models (Singh et al., 1987; Hampson et al., 1989; Grounds et al., 1991; Hagenaars et al., 1994; Singh et al., 1994; Harvey et al., 1997). Our data suggest a direct migration of macrophages between the transplanted and recipient nerves without passing through the circulation. The question whether macrophages that leave the transplanted nerve and enter the bloodstream then reenter an area of nerve damage remains open and could only be answered under the condition when the host nerve is crushed but not cut. However, it is not known whether the degenerative process in crushed nerves occurs differently from that in cut nerves; it should be assumed that macrophage migration into a crushed nerve is slower than into a transected nerve. To ascertain similar experimental conditions for both, the transplanted and the recipient nerve, we decided to use the transection model for both nerves.
In our experiments, we detected 145SC5-positive cells at all time points after transplantation (2–40 d) within the spleen and lymph nodes, indicating active migration via lymphatic and blood vessels. There is little knowledge on the migration of macrophages from the periphery to lymphatic organs. Macrophages injected in the splenic artery reach the splenic parenchyma within few minutes and remain there for at least 36 hr (Miyakawa et al., 1990). Directed migration of cells is generally regulated by a group of molecules designated as chemokines. These chemokines belong to different families, attract different leukocyte subpopulations, and are ligands for specific receptors (Baggiolini et al., 1994, 1997; Raport et al., 1996; Rollins, 1997). We and others have demonstrated a crucial role for the chemokine MCP-1 and its receptor CCR2 during macrophage recruitment into transected peripheral nerves (Toews et al., 1998; Siebert et al., 2000). Furthermore, a critical role for the chemokine receptor CCR-7 on dendritic cells has been shown in the migration from tumor sites to draining lymph nodes, especially after interaction with apoptotic tumor cells (Hirao et al., 2000). Similar mechanisms could play a role in our experimental model when macrophages move to the lymph nodes and spleen. Several other factors such as state of maturation, tissue origin, matrix structure, and proinflammatory cytokines have been shown to be involved in the migration of dendritic cells within collagen lattices (Gunzer et al., 2000).
The local and systemic elimination of myelin-laden macrophages may also have implications for the development of subsequent autoimmune disorders. Thus, the migration of myelin-presenting macrophages to lymph nodes and the spleen raises the possibility of the induction of an autoimmune process. In general, Wallerian degeneration in the nervous system is not followed by an autoimmune attack (Wekerle et al., 1986). However, in animal models it has been shown that traumatic lesions may predispose the nervous tissue for developing inflammatory autoimmune reactions (Maehlen et al., 1989; Konno et al., 1990).
In conclusion, the present data indicate that two mechanisms are involved in the disappearance of macrophages from the damaged peripheral nerve: local apoptosis and immigration into the lymph nodes and spleen. Systemic elimination via lymph nodes and spleen is a process that requires active and directed migration of the cells. Further experiments have to clarify the exact mechanisms leading to macrophage apoptosis as well as the molecular signals involved in the directed migration of macrophages to lymphatic organs.
Footnotes
Antiserum against activated caspase-3 was kindly provided by T. L. Deckwerth and Anu Srinivasan. We thank Brigitte Maruschak and Stephanie Bunkowski for excellent technical assistance.
Correspondence should be addressed to Dr. Wolfgang Brück, Department of Neuropathology, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany. E-mail:wolfgang.brueck{at}charite.de.